Trial intelligence / Profile preview

ADJetflu adolescent influenza vaccine jet injector study

jRCTs052260189Recruiting

Sponsor
Daicel Medical
Start
Oct 2026
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of seasonal influenza hemagglutinin vaccine in seasonal influenza (2 arms), sponsored by Daicel Medical. Primary endpoint: Immunogenicity at Day 22. Started Oct 2026; status: recruiting.

02

Drugs

seasonal influenza hemagglutinin vaccine
03

Conditions

seasonal influenza

Beyond the preview

Go deeper on jRCTs052260189.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs052260189.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call